PCNA and GSK3β interact with each other to regulate H1299 lung adenocarcinoma cells apoptosis
1Key Laboratory of Functional Protein Research of Guangdong Higher Education Institute, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, Guangzhou, China.
Abstract:
Glycogen synthase kinase beta (GSK3β) is considered as a promising target for lung cancer treatment and its inhibitor lithium chloride (LiCl) is widely regarded as having potent anti-proliferative and apoptosis-modulating activities. Proliferating cell nuclear antigen (PCNA), as an auxiliary protein for DNA polymerase delta, which regulates DNA replication and repair, has been reported to play an important role in regulating apoptosis. Here, we showed that GSK3β interacted with PCNA in H1299 lung adenocarcinoma cells using GST pull-down and co-immunoprecipitation experiments. We discovered that their interaction can be enhanced within the first 3 h after UVC irradiation and decreased gradually with time. Overexpression of PCNA protein decreased GSK3β Ser9 phosphorylation, whereas knockdown of PCNA using small interfering RNA (siRNA) increased Ser9 phosphorylated GSK3β, which was attenuated by phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 after UVC irradiation, indicating the involvement of the PI3K-AKT pathway. Functional analyses suggested that downregulation of PCNA sensitized H1299 cells to LiCl-induced apoptosis. Thus, our results unraveled a novel regulatory of GSK3β by PCNA and provided a promising direction for treatment of lung cancer.
Insights
Lithium chloride (LiCl) targets glycogen synthase kinase beta (GSK3β) for lung cancer treatment. This study reveals GSK3β interacts with proliferating cell nuclear antigen (PCNA), influencing apoptosis and LiCl sensitivity.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Signaling
Background:
- Glycogen synthase kinase beta (GSK3β) is a key target for lung cancer therapy, with its inhibitor lithium chloride (LiCl) showing anti-proliferative and apoptosis-modulating effects.
- Proliferating cell nuclear antigen (PCNA) is crucial for DNA replication and repair, and its role in apoptosis regulation is significant.
Purpose of the Study:
- To elucidate the interaction between GSK3β and PCNA in lung adenocarcinoma cells.
- To investigate the regulatory mechanism of GSK3β by PCNA, particularly in response to DNA damage.
- To determine the functional consequence of the GSK3β-PCNA interaction on lung cancer cell apoptosis and response to LiCl treatment.
Main Methods:
- GST pull-down and co-immunoprecipitation assays to confirm GSK3β-PCNA interaction in H1299 cells.
- UVC irradiation to study the dynamic changes in GSK3β-PCNA interaction.
- Western blotting to assess GSK3β Ser9 phosphorylation levels following PCNA manipulation (overexpression and siRNA knockdown).
- Pharmacological inhibition of phosphatidylinositol 3-kinase (PI3K) using LY294002 to probe pathway involvement.
- Functional assays to evaluate the effect of PCNA downregulation on LiCl-induced apoptosis.
Main Results:
- GSK3β was found to interact with PCNA in H1299 lung adenocarcinoma cells.
- The GSK3β-PCNA interaction intensity peaked within 3 hours post-UVC irradiation and subsequently decreased.
- PCNA overexpression reduced GSK3β Ser9 phosphorylation, while PCNA knockdown increased it, an effect reversed by LY294002, implicating the PI3K-AKT pathway.
- Downregulation of PCNA enhanced the sensitivity of H1299 cells to LiCl-induced apoptosis.
Conclusions:
- A novel regulatory interaction between GSK3β and PCNA has been identified in lung adenocarcinoma.
- The PI3K-AKT pathway plays a role in modulating GSK3β phosphorylation in response to PCNA levels and DNA damage.
- Targeting the PCNA-GSK3β axis presents a promising therapeutic strategy for lung cancer, potentially enhancing LiCl efficacy.
More Related Videos
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
GPCRs Regulate Adenylyl Cylase Activity
Inhibition of Cdk Activity
Amplifying Signals via Enzymatic Cascade
Negative Regulator Molecules
The JAK-STAT Signaling Pathway


